Cell programming and youth restoration

Listen to the article. The audio text is automated, generated by an automated system

In the computer age, everything has become programmable, even the cells of your body! Imagine a cell that has aged, and its ability to repair itself has weakened. Then scientists came to change the way it works so that it regains some of its old activity. This is the idea behind partial reprogramming of cells, one of the most exciting aging researches today, and it is an attempt to repair what happened to the cell over time. There is no ready-made recipe for returning youth to a person.

The story began with the discovery that a group of proteins, known as Yamanaka factors, can transform adult cells into cells similar to stem cells. It was an amazing discovery, but it also revealed a problem, which is that complete reprogramming erases the identity of the cell. An eye cell, for example, must remain an eye cell in order to perform its function, so researchers are trying to activate some of these factors for a limited period, hoping that the cell will regain more youthful characteristics before it loses its identity.

But what changes inside it? With age, “epigenetic marks” change, which are signals that help the cell determine which genes to turn on and which genes to turn off, without changing the DNA sequence itself. Partial reprogramming targets some of these patterns, and experiments on cells in the laboratory and animals have shown improvement in specific cellular indicators and functions, the most famous examples of which are improved regeneration of eye nerves and some measures of vision in mice.

In 2026, the idea reached an early human trial. Life Biosciences is testing a treatment called ER-100 in people who have suffered damage to the optic nerve, including glaucoma patients. In October, the company announced that the first three participants tolerated the treatment within 56 days, with initial indications of an improvement in visual field testing in two of them. This is data that the company announced on a small number of patients.

The experiment is still ongoing, and its primary goal is to evaluate safety, and its results are not sufficient to prove the effectiveness of the treatment. The most difficult challenge remains controlling the process: the amount of reprogramming, how long it will continue, and whether its effect lasts without increasing the risk of uncontrolled cellular growth. Renewing some cell properties has become a question that is subject to scientific experimentation. As for full body rejuvenation, it is still a hypothesis awaiting evidence.